Average Co-Inventor Count = 8.96
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (15 from 379 patents)
2. Bayer Aktiengesellschaft (10 from 12,170 patents)
3. Seattle Genetics, Inc. (4 from 132 patents)
4. Beiersdorf Ag (1 from 540 patents)
27 patents:
1. 12144865 - Antibody drug conjugates with enzymatically cleavable groups
2. 12065497 - Methods of treatment using CCR8 antibodies
3. 12059472 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups
4. 11806404 - Site specific homogeneous with KSP inhibitors
5. 11685714 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups
6. 11660351 - Antibody drug conjugates (ADCs) having enzymatically cleavable groups
7. 11643469 - Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
8. 11478554 - Antibody drug conjugates (ADCS) having enzymatically cleavable groups
9. 11433140 - Specific antibody drug conjugates (ADCs) having KSP inhibitors
10. 11123439 - Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups
11. 11071788 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
12. 11001636 - Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
13. 10973923 - Site specific homogeneous with KSP inhibitors
14. 10744205 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies
15. 10485880 - Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies